Patent · US Active

Nucleic acids and polypeptides specific of the Neisseria genus pathogenic strains

US8309100B2 · kind B2 · utility

1Cited by

0References

6Claims

0Family size

Assignees

Aventis Pasteur · CA
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

Luc Aujame · Écully, FR
Annabelle Bouchardon · Val-de-Reuil, FR
Genevieve Renauld-Mongenie · Chaponost, FR
Bachra Rokbi · Val-de-Reuil, FR
Xavier Nassif · Paris, FR
Colin Tinsley · Paris, FR
Agnès Perrin · Paris, FR

Key dates

Filing date	Feb 4, 2010
Grant date	Nov 13, 2012
Priority date	—
Expiry date	Feb 4, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/51
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns nucleic acids coding for polypeptides specific of the Neisseria genus pathogenic strains, the corresponding polypeptides, and their diagnostic and therapeutic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.